Related Experiment Video

Updated: Dec 14, 2025

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

Commentary in reply to a publication on Plasmodium falciparum pre-erythrocytic stage vaccine development

François P Roman¹, Margherita Coccia², Lode Schuerman²

¹GSK, Avenue Fleming 20, 1300, Wavre, Belgium. francois.p.roman@GSK.COM.

Malaria Journal

|July 22, 2020

Abstract:

We have read the publication of Molina-Franky and colleagues on Plasmodium falciparum pre-erythrocytic stage vaccine development (Malaria Journal, 2020;19:56). The commentary revises some of their statements on the RTS,S/AS01 vaccine that are considered either imprecise or incorrect.

Keywords:

Clinical studies Malaria vaccine RTS,S/AS01

More Related Videos

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

Generating Genetically Modified Plasmodium berghei Sporozoites

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Assessing safety in the RTS,S/AS01 malaria vaccine implementation programme: an overview and comparison of methods.

Malaria journal·2026

Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi.

The Lancet. Global health·2025

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial.

The Lancet. Global health·2025

Incidence rates of malaria, meningitis, and mortality in children younger than 5 years: a prospective cohort study in Ghana and Kenya before the roll-out of the RTS,S/AS01E malaria vaccine from 2016 to 2022.

The Lancet. Global health·2025

Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study.

The Lancet. Global health·2025

System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans.

Nature immunology·2025

See all related articles